BACKGROUND: End stage renal disease patients are treated with dialysis in Nepal. But there is no renal registry to indicate the burden of disease in the country. OBJECTIVES: The objective of this study is to find out the incidence of ESRD on renal replacement therapy and their out come. MATERIALS AND METHODS: It is a retrospective analysis (audit) of all ESRD patients who had received dialysis inside Nepal and had under gone transplantation from 1990 to 1999. The haemodialysis (HD) registry, HD patients file, intermittent peritoneal dialysis (IPD) registry of Bir Hospital, Shree Birendra Hospital, Tribhuwan University Teaching hospital and National Kidney Center were reviewed. Acute renal failure and acute on chronic renal failure were excluded and the demographic profile, dialysis session, dialysis duration and outcome of all ESRD patients were computed. One patient was counted only once in spite of attending more than one center for dialysis. SPSS package was used for analysis. RESULTS: Total number of 1393 ESRD patients received renal replacement therapy (RRT) in the decade. Mean age of patients were 46.7 +/- 16.7 with 70% of ESRD were between 20-60 years age with male: female ratio of 1.8:1. Initial mode of RRT was IPD in 58.2%, HD in 41.7% and pre-emptive transplantation in 0.1% patients. Records of 189 patients could not be found and out of remaining 1208 patients, 85.8% received dialysis for < 3 months, 6% received dialysis for more than a year and 9.5% had undergone kidney transplantation. The incidence of ESRD had increased gradually with 3.4 per million populations (pmp) in 1990 to 11.89 pmp in 1999 with an average annual incidence of 6 pmp and only 0.31% of expected ESRD patients received RRT. CONCLUSION: The incidence of ESRD is increasing but majority discontinue or die within 3 months. Dialysis centers needs to be expanded to different parts of country and prospective studies have to be carried out to fi nd out of cause of ESRD and to institute preventive measures.
BACKGROUND:End stage renal diseasepatients are treated with dialysis in Nepal. But there is no renal registry to indicate the burden of disease in the country. OBJECTIVES: The objective of this study is to find out the incidence of ESRD on renal replacement therapy and their out come. MATERIALS AND METHODS: It is a retrospective analysis (audit) of all ESRDpatients who had received dialysis inside Nepal and had under gone transplantation from 1990 to 1999. The haemodialysis (HD) registry, HDpatients file, intermittent peritoneal dialysis (IPD) registry of Bir Hospital, Shree Birendra Hospital, Tribhuwan University Teaching hospital and National Kidney Center were reviewed. Acute renal failure and acute on chronic renal failure were excluded and the demographic profile, dialysis session, dialysis duration and outcome of all ESRDpatients were computed. One patient was counted only once in spite of attending more than one center for dialysis. SPSS package was used for analysis. RESULTS: Total number of 1393 ESRDpatients received renal replacement therapy (RRT) in the decade. Mean age of patients were 46.7 +/- 16.7 with 70% of ESRD were between 20-60 years age with male: female ratio of 1.8:1. Initial mode of RRT was IPD in 58.2%, HD in 41.7% and pre-emptive transplantation in 0.1% patients. Records of 189 patients could not be found and out of remaining 1208 patients, 85.8% received dialysis for < 3 months, 6% received dialysis for more than a year and 9.5% had undergone kidney transplantation. The incidence of ESRD had increased gradually with 3.4 per million populations (pmp) in 1990 to 11.89 pmp in 1999 with an average annual incidence of 6 pmp and only 0.31% of expected ESRDpatients received RRT. CONCLUSION: The incidence of ESRD is increasing but majority discontinue or die within 3 months. Dialysis centers needs to be expanded to different parts of country and prospective studies have to be carried out to fi nd out of cause of ESRD and to institute preventive measures.
Authors: Suceena Alexander; Sanjiv Jasuja; Maurizio Gallieni; Manisha Sahay; Devender S Rana; Vivekanand Jha; Shalini Verma; Raja Ramachandran; Vinant Bhargava; Gaurav Sagar; Anupam Bahl; Mamun Mostafi; Jayakrishnan K Pisharam; Sydney C W Tang; Chakko Jacob; Atma Gunawan; Goh B Leong; Khin T Thwin; Rajendra K Agrawal; Kriengsak Vareesangthip; Roberto Tanchanco; Lina H L Choong; Chula Herath; Chih C Lin; Nguyen T Cuong; Ha P Haian; Syed F Akhtar; Ali Alsahow; Mohan M Rajapurkar; Vijay Kher; Hemant Mehta; Anil K Bhalla; Umesh B Khanna; Deepak S Ray; Sonika Puri; Himanshu Jain; Aida Lydia; Tushar Vachharajani Journal: Int J Nephrol Date: 2021-05-06